Bayer Is Making Inroads in Gene Therapy through Asklepios Acquisition
Bayer AG will acquire Asklepios BioPharmaceutical Inc. (AskBio), a U.S. biotech firm, for $4 billion as the German pharmaceutical and chemical market bets on gene therapy, according to the company's…